Is IPG Photonics (IPGP) Fully Valued Following Its Earnings Beat And Industrial Growth?

IPG Photonics earnings beat puts Industrial Solutions in focus

IPG Photonics (IPGP) has drawn fresh attention after reporting second-quarter 2026 adjusted earnings of $0.58 per share, ahead of estimates, with revenue rising 11% year over year on strength in its Industrial Solutions segment.

The earnings beat comes after a tough run for IPG Photonics shareholders, with the share price down 18.7% over the past month and 28.8% over the past quarter. The 1-year total shareholder return has declined 7.1% and the 5-year total shareholder return is down 56.1%, indicating longer term momentum has been weak even as recent results hint at improving sentiment.

Compare IPG Photonics with a curated group of industrial and tech stocks that also show improving earnings momentum via the 21 high quality undiscovered gems.

IPG Photonics just showed it can still grow earnings and revenue, yet the stock has fallen sharply over the past quarter. Is this a solid laser business temporarily marked down, or a fair price for its risks?

Most Popular Narrative: 41.4% Undervalued

The most followed narrative pegs IPG Photonics at a fair value of $130.50 compared with the last close at $76.46. That gap is built on a detailed set of growth and margin assumptions.

New growth initiatives in medical (e.g., thulium lasers for urology), semiconductor, and micromachining end-markets are gaining early traction, diversifying revenue streams and supporting higher margins over time as these higher-value verticals scale. Recent product innovations like the CROSSBOW directed energy system, validated with multiple unit deliveries and key partnerships (e.g., Lockheed Martin), open up opportunities in defense and critical infrastructure, supporting both revenue acceleration and improved operating leverage.

Read the complete narrative.

Want to see what kind of revenue build, margin lift and future profit multiple it takes to back that $130.50 fair value for IPG Photonics? The narrative leans on a rapid earnings ramp, a richer mix from higher value segments, and a premium valuation usually reserved for faster growing electronics stocks.

Result: Fair Value of $130.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the bullish IPG Photonics narrative still hinges on recovering materials processing demand, as well as on newer medical and defense applications scaling fast enough to justify richer P/E assumptions.

Find out about the key risks to this IPG Photonics narrative.

Another view on IPG Photonics valuation

The popular narrative frames IPG Photonics as materially undervalued, yet the current P/E of 118x tells a different story. That multiple is far above the US Electronic industry average of 28.9x and also above the company’s own fair ratio of 58.6x. This points to elevated valuation risk rather than a clear bargain. How comfortable are you paying roughly double that fair ratio for a business that only recently returned to profitability?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed sentiment around IPG Photonics, this is a moment to move quickly and check the underlying data yourself. Weigh the downside and upside drivers using the 3 key rewards and 1 important warning sign.

Looking for more IPG Photonics investment ideas?

If IPG Photonics has your attention, do not stop here. Broaden your watchlist with fresh stock ideas that match your risk level and income goals.

• Target potential bargains by scanning a curated set of quality companies that trade below their estimated value with the 52 high quality undervalued stocks.
• Strengthen your income stream by focusing on companies offering higher yields and robust payout profiles through the 11 dividend fortresses.
• Prioritise resilience by filtering for companies with strong balance sheets and solid fundamentals using the list of solid balance sheet and fundamentals (53 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com